The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

DNA analysis for donor screening of Dombrock blood group antigens

Author

  • Jill Storry
  • C M Westhoff
  • D Charles-Pierre
  • M Rios
  • K Hue-Roye
  • S Vege
  • S Nance
  • M E Reid

Summary, in English

Due to the scarcity of reliable antibodies, RBC typing for Doa and Dob is notoriously difficult. Inaccurate typing can place patients at risk for hemolytic transfusion reactions. The molecular basis of the DOA/DOB polymorphism is associated with three nucleotide changes:378 C>T, 624 T>C,and 793 A>G of DO. While the 378 C>T and 624 T>C are silent mutations, the 793A>G polymorphism in codon 265 encodes asparagine for Doa and aspartic acid for Dob. We describe here the use of a PCR-RFLP assay as an alternative to traditional hemagglutination for typing donor blood for Dombrock. Primers were designed to amplify the region of DO containing the 793A>G polymorphism. DNA samples from blood donors were amplified and subjected to RFLP analysis. A total of 613 samples were tested for the Dombrock polymorphism (793 A>G) by PCRRFLP. PCR-RFLP can be used to screen for Do(a-) or Do(b-) donors. This approach overcomes the scarcity of the reagents required for testing by hemagglutination.

Publishing year

2003

Language

English

Pages

73-76

Publication/Series

Immunohematology

Volume

19

Issue

3

Document type

Journal article

Publisher

American Red Cross

Topic

  • Hematology

Keywords

  • PCR-RFLP
  • Dombrock blood group system
  • Dombrock polymorphisms Doa/Dob
  • typingdonors

Status

Published

ISBN/ISSN/Other

  • ISSN: 0894-203X